CLassification of Axial SpondyloarthritiS Inception Cohort

CompletedOBSERVATIONAL
Enrollment

501

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

August 22, 2022

Study Completion Date

August 22, 2022

Conditions
Spondyloarthritis
Trial Locations (20)

10032

Columbia University, New York

10468

James J. Peters VAMC, The Bronx

39216

University of Mississippi Medical Center, Jackson

44195

Cleveland Clinic, Cleveland

44690

Centro de Estudios de Investigacion Basica y Clinica, SC, Guadalajara

75216

Dallas VA Medical Center VANTHCS, Dallas

77030

University of Texas Health Science Center at Houston, Houston

80045

University of Colorado, Aurora

90822

VA Long Beach Healthcare System, Long Beach

94143

UCSF Medical Center - Rheumatology Clinic, San Francisco

95655

Sacramento VA Medical Center, Mather

97239

Oregon Health & Science University, Portland

98122

Seattle Rheumatology Associates, Seattle

06067

Yale University School of Medicine, New Haven

02115

Brigham & Women's Hospital, Boston

02118

Boston University School of Medicine, Boston

V5Z 1L9

Artus Health Center, Vancouver

K1H 7W9

The Ottawa Hospital, Ottawa

M5T2S8

University Health Network, Toronto

06700

CLIDITER, Mexico City

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

collaborator

Amgen

INDUSTRY

collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

UCB Pharma

INDUSTRY

lead

Spondyloarthritis Research and Treatment Network

NETWORK